Word

HINYE PHARMA

Status

Registered

Status Code

700

Status Date

Tuesday, August 2, 2022

Serial Number

79323511

Registration Number

6805693

Registration Date

Tuesday, August 2, 2022

Mark Type

3000

Filing Date

Monday, June 28, 2021

Published for Opposition

Tuesday, May 17, 2022

Trademark Owner History

Hinye Pharmaceutical Co.,Ltd. - Original Registrant

Classifications

5 Herbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; Chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; anti-allergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammatory disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; unit dose capsules sold empty for pharmaceutical use; biological preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; allergy tablets; antibiotic tablets

The design element appearing to the left of the Chinese characters and wording is comprised of a diamond embedded with a notch and a long curved line. To the right of the design element appears four Chinese characters in horizontal arrangement above the wording HINYE PHARMACY.
The transliteration of the non-Latin characters in the mark is Tian Di Heng YI.
The four Chinese characters Tian Di Heng YI are translated as HINYE. The Chinese characters in the mark and the wording HINYE have no meaning in English.
"PHARMA"

Trademark Events

Oct 2, 2022

Notification Processed By Ib

Sep 15, 2022

Final Disposition Notice Sent To Ib

Sep 15, 2022

Final Disposition Processed

Sep 1, 2022

Grant Of Protection Created, To Be Sent To Ib

Aug 2, 2022

Registered-Principal Register

May 17, 2022

Published For Opposition

May 16, 2022

Notification Processed By Ib

Apr 27, 2022

Notification Of Possible Opposition Sent To Ib

Apr 27, 2022

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 27, 2022

Notice Of Publication

Apr 10, 2022

Approved For Pub - Principal Register

Mar 18, 2022

Assigned To Examiner

Nov 6, 2021

Application Filing Receipt Mailed

Nov 2, 2021

New Application Office Supplied Data Entered In Tram

Oct 30, 2021

Limitation From Original Application Entered

Oct 22, 2021

Sn Assigned For Sect 66a Appl From Ib